Document Detail


Studies with inulin-type fructans on intestinal infections, permeability, and inflammation.
MedLine Citation:
PMID:  17951504     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Symbiosis between host and gut bacteria can be optimized by prebiotics. Inulin-type fructans have been shown to improve the microbial balance of the intestinal ecosystem by stimulating the growth of bifidobacteria and lactobacilli. These changes have been associated with several health benefits, including the prevention of gastrointestinal and systemic infections in animal models and human studies. Inulin-type fructans induce changes of the intestinal mucosa characterized by higher villi, deeper crypts, increased number of goblet cells, and a thicker mucus layer on the colonic epithelium. Bacterial antagonism and competition of bifidobacteria and lactobacilli with pathogens, as well as the trophic effects on the intestinal epithelium, may explain the protective role of inulin against enteric infections. In contrast, studies with rats fed a low-calcium diet suggested a negative effect of prebiotics on intestinal barrier function. However, the adverse effect was clearly ascribed to the strong reduction of dietary calcium, as it could be reversed by oral administration of calcium. The adverse effect of a low-calcium diet on intestinal permeability has not been observed in humans. Inulin and oligofructose are now being tested in human studies aimed at prevention of bacterial translocation in critical health conditions. Mixtures of probiotics and prebiotics including inulin or oligofructose significantly reduced the rate of postoperative infections in liver transplant patients. Finally, inulin and oligofructose have proven useful to prevent mucosal inflammatory disorders in animal models and in patients with inflammatory bowel disease.
Authors:
Francisco Guarner
Related Documents :
345484 - The use of neurolept analgesia for gastro-intestinal endoscopy.
1237444 - Carnosinase activity of human gastrointestinal mucosa.
8179004 - Rapid upregulation of snake intestine in response to feeding: a new model of intestinal...
16988114 - Increased luminal mucin does not disturb glucose or ovalbumin absorption in rats fed in...
8345414 - Daily energy expenditure by five-year-old children, measured by doubly labeled water.
8457524 - The effect of replacement of dietary fat by palm oil on in vitro cytokine release.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Journal of nutrition     Volume:  137     ISSN:  0022-3166     ISO Abbreviation:  J. Nutr.     Publication Date:  2007 Nov 
Date Detail:
Created Date:  2007-10-22     Completed Date:  2007-12-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0404243     Medline TA:  J Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2568S-2571S     Citation Subset:  IM    
Affiliation:
Digestive System Research Unit, University Hospital Vall d'Hebron, CIBEREHD, Barcelona, Spain. fguarner@vhebron.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Fructans / pharmacology,  therapeutic use*
Gastroenteritis / drug therapy,  microbiology,  prevention & control*
Humans
Inflammatory Bowel Diseases / drug therapy,  microbiology,  prevention & control*
Intestinal Mucosa / drug effects*,  microbiology
Inulin / pharmacology,  therapeutic use*
Permeability / drug effects
Chemical
Reg. No./Substance:
0/Fructans; 9005-80-5/Inulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inulin and oligofructose: review of experimental data on immune modulation.
Next Document:  Inulin and oligofructose in chronic inflammatory bowel disease.